Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors.

Falchook, G. S., Venkatakrishnan, K., Sarantopoulos, J., Kurzrock, R., Mita, A. C., Fu, S., Mita, M. M., Zhou, X., Jung, J. A., Ullmann, C. D., Milch, C. & Rosen, L. S.

Int. J. Clin. Pharmacol. Ther. 53, 563-572 (2015). PMID: 26073352

http://www.ncbi.nlm.nih.gov/pubmed/?term=26073352